uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
The metabolic consequences of thyroxine replacement in adult hypopituitary patients
Show others and affiliations
2012 (English)In: Pituitary, ISSN 1386-341X, E-ISSN 1573-7403, Vol. 15, no 4, 495-504 p.Article in journal (Refereed) Published
Abstract [en]

The metabolic consequences of thyroxine replacement in patients with central hypothyroidism (CH) need to be evaluated. The aim was to examine the outcome of thyroxine replacement in CH. Adult hypopituitary patients (n = 1595) with and without CH from KIMS (Pfizer International Metabolic Database) were studied before and after 2 years of GH replacement. CH patients (CH, n = 1080) were compared with TSH sufficient patients (TSHsuff n = 515) as one group and divided by thyroxine dose/kg/day into tertiles (CHlow-mid-high). Anthropometry, fasting glucose, glycosylated haemoglobin (HbA1c), blood pressure, lipids, IGF-I SDS, quality of life and morbidity were studied. Analyses were standardized for gender, age, number and types of pituitary insufficiencies, stimulated GH peak, age at GH deficiency onset, aetiologies and, when appropriate, for weight and GH dose. At baseline, TSHsuff patients did not differ from CH or CHmid in any outcome. CHlow (a parts per thousand currency sign1.18 mu g thyroxine/kg/day) had increased weight, BMI and larger waist circumference (WC), CHhigh (a parts per thousand yen1.58 mu g thyroxine/kg/day) had lower weight, BMI, WC and IGF-I than TSHsuff and compared to their predicted weights, BMIs and WCs. For every 0.1 mu g/kg/day increase of thyroxine dose, body weight decreased 1.0 kg, BMI 0.3 kg/m(2), and WC 0.65 cm. The GH sensitivity of the CH group was higher (0.76 +/- A 0.56 SDS/mg GH) than that of TSHsuff patients (0.58 +/- A 0.64 SDS/mg GH), P < 0.001. The middle thyroxine dose (1.19-1.57 mu g/kg/day) seems to be the most physiological. This is equivalent to 70, 100, 125 mu g thyroxine/day for hypopituitary patients of 50, 70 or 90 kg weight, respectively.

Place, publisher, year, edition, pages
2012. Vol. 15, no 4, 495-504 p.
Keyword [en]
Central hypothyroidism, Thyroxine dose, Hypopituitarism, GHD
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-187625DOI: 10.1007/s11102-011-0356-6ISI: 000310898400006OAI: oai:DiVA.org:uu-187625DiVA: diva2:575447
Available from: 2012-12-10 Created: 2012-12-10 Last updated: 2012-12-10Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text
By organisation
Department of Women's and Children's Health
In the same journal
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 182 hits
ReferencesLink to record
Permanent link

Direct link